Connection
Augusto Miravalle to Treatment Outcome
This is a "connection" page, showing publications Augusto Miravalle has written about Treatment Outcome.
|
|
Connection Strength |
|
 |
|
 |
|
0.044 |
|
|
|
-
Miravalle A, Jensen R, Kinkel RP. Immune reconstitution inflammatory syndrome in patients with multiple sclerosis following cessation of natalizumab therapy. Arch Neurol. 2011 Feb; 68(2):186-91.
Score: 0.035
-
Nielsen AS, Miravalle A, Langer-Gould A, Cooper J, Edwards KR, Kinkel RP. Maximally tolerated versus minimally effective dose: the case of rituximab in multiple sclerosis. Mult Scler. 2012 Mar; 18(3):377-8.
Score: 0.009